Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGS and Targeted Therapy in Stage II-III Breast Cancer
NCT01959490Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Sep 2013
- Primary completion
- Nov 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab, pertuzumab, bevacizumab in breast cancer, sponsored by Case Comprehensive Cancer Center. Started Sep 2013; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01959490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959490.